Cargando…

Clinically Significant Pleural Effusion in Intensive Care: A Prospective Multicenter Cohort Study

OBJECTIVES: The prevalence and optimal management of clinically significant pleural effusion, confirmed by thoracic ultrasound, in the critically ill is unknown. This study aimed to determine: 1) the prevalence, characteristics, and outcomes of patients treated in intensive care with clinically sign...

Descripción completa

Detalles Bibliográficos
Autores principales: Fysh, Edward T. H., Smallbone, Portia, Mattock, Nicholas, McCloskey, Cassandra, Litton, Edward, Wibrow, Bradley, Ho, Kwok M., Lee, Y. C. Gary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063904/
https://www.ncbi.nlm.nih.gov/pubmed/32166290
http://dx.doi.org/10.1097/CCE.0000000000000070
_version_ 1783504780459507712
author Fysh, Edward T. H.
Smallbone, Portia
Mattock, Nicholas
McCloskey, Cassandra
Litton, Edward
Wibrow, Bradley
Ho, Kwok M.
Lee, Y. C. Gary
author_facet Fysh, Edward T. H.
Smallbone, Portia
Mattock, Nicholas
McCloskey, Cassandra
Litton, Edward
Wibrow, Bradley
Ho, Kwok M.
Lee, Y. C. Gary
author_sort Fysh, Edward T. H.
collection PubMed
description OBJECTIVES: The prevalence and optimal management of clinically significant pleural effusion, confirmed by thoracic ultrasound, in the critically ill is unknown. This study aimed to determine: 1) the prevalence, characteristics, and outcomes of patients treated in intensive care with clinically significant effusion and 2) the comparative efficacy and safety of pleural drainage or expectant medical management. DESIGN: A prospective multicenter cohort study. SETTING: ICUs in four teaching hospitals in Western Australia. PATIENTS: Consecutive patients with clinically significant pleural effusions (depth ≥ 2 cm on thoracic ultrasound with clinician-determined adverse effects on patient progress). INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Primary outcome was the change in Pao(2):Fio(2) (mm Hg) ratio from baseline to 24 hours. Changes in diagnosis and treatment based on pleural fluid analysis and pleural effusion related serious adverse events between those who underwent either drainage within 24 hours or expectant management were compared. Of the 7,342 patients screened, 226 patients (3.1%) with 300 pleural effusions were enrolled. Early drainage of pleural effusion occurred in 76 patients (34%) and significantly improved oxygenation (Pao(2):Fio(2) ratio 203 at baseline vs 263 at 24 hr, +29.6% increment; p < 0.01). This was not observed in the other 150 patients who had expectant management (Pao(2):Fio(2) ratio 250 at baseline vs 268 at 24 hr, +7.2% increment; p = 0.44). The improvement in oxygenation after early drainage remained unchanged after adjustment for a propensity score on the decision to initiate early drainage. Pleural effusion related serious adverse events were not different between the two groups (early drainage 10.5% vs no early drainage 16.0%; p = 0.32). Improvements in diagnosis were noted in 91 initial (nonrepetitive) drainages (76.5% out of 119); treatment strategy was optimized after 80 drainage episodes (59.7% out of 134). CONCLUSIONS: Early drainage of clinically significant pleural effusion was associated with improved oxygenation and diagnostic accuracy without increased complications.
format Online
Article
Text
id pubmed-7063904
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-70639042020-03-12 Clinically Significant Pleural Effusion in Intensive Care: A Prospective Multicenter Cohort Study Fysh, Edward T. H. Smallbone, Portia Mattock, Nicholas McCloskey, Cassandra Litton, Edward Wibrow, Bradley Ho, Kwok M. Lee, Y. C. Gary Crit Care Explor Observational Studies OBJECTIVES: The prevalence and optimal management of clinically significant pleural effusion, confirmed by thoracic ultrasound, in the critically ill is unknown. This study aimed to determine: 1) the prevalence, characteristics, and outcomes of patients treated in intensive care with clinically significant effusion and 2) the comparative efficacy and safety of pleural drainage or expectant medical management. DESIGN: A prospective multicenter cohort study. SETTING: ICUs in four teaching hospitals in Western Australia. PATIENTS: Consecutive patients with clinically significant pleural effusions (depth ≥ 2 cm on thoracic ultrasound with clinician-determined adverse effects on patient progress). INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Primary outcome was the change in Pao(2):Fio(2) (mm Hg) ratio from baseline to 24 hours. Changes in diagnosis and treatment based on pleural fluid analysis and pleural effusion related serious adverse events between those who underwent either drainage within 24 hours or expectant management were compared. Of the 7,342 patients screened, 226 patients (3.1%) with 300 pleural effusions were enrolled. Early drainage of pleural effusion occurred in 76 patients (34%) and significantly improved oxygenation (Pao(2):Fio(2) ratio 203 at baseline vs 263 at 24 hr, +29.6% increment; p < 0.01). This was not observed in the other 150 patients who had expectant management (Pao(2):Fio(2) ratio 250 at baseline vs 268 at 24 hr, +7.2% increment; p = 0.44). The improvement in oxygenation after early drainage remained unchanged after adjustment for a propensity score on the decision to initiate early drainage. Pleural effusion related serious adverse events were not different between the two groups (early drainage 10.5% vs no early drainage 16.0%; p = 0.32). Improvements in diagnosis were noted in 91 initial (nonrepetitive) drainages (76.5% out of 119); treatment strategy was optimized after 80 drainage episodes (59.7% out of 134). CONCLUSIONS: Early drainage of clinically significant pleural effusion was associated with improved oxygenation and diagnostic accuracy without increased complications. Wolters Kluwer Health 2020-01-29 /pmc/articles/PMC7063904/ /pubmed/32166290 http://dx.doi.org/10.1097/CCE.0000000000000070 Text en Copyright © 2020 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Observational Studies
Fysh, Edward T. H.
Smallbone, Portia
Mattock, Nicholas
McCloskey, Cassandra
Litton, Edward
Wibrow, Bradley
Ho, Kwok M.
Lee, Y. C. Gary
Clinically Significant Pleural Effusion in Intensive Care: A Prospective Multicenter Cohort Study
title Clinically Significant Pleural Effusion in Intensive Care: A Prospective Multicenter Cohort Study
title_full Clinically Significant Pleural Effusion in Intensive Care: A Prospective Multicenter Cohort Study
title_fullStr Clinically Significant Pleural Effusion in Intensive Care: A Prospective Multicenter Cohort Study
title_full_unstemmed Clinically Significant Pleural Effusion in Intensive Care: A Prospective Multicenter Cohort Study
title_short Clinically Significant Pleural Effusion in Intensive Care: A Prospective Multicenter Cohort Study
title_sort clinically significant pleural effusion in intensive care: a prospective multicenter cohort study
topic Observational Studies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063904/
https://www.ncbi.nlm.nih.gov/pubmed/32166290
http://dx.doi.org/10.1097/CCE.0000000000000070
work_keys_str_mv AT fyshedwardth clinicallysignificantpleuraleffusioninintensivecareaprospectivemulticentercohortstudy
AT smallboneportia clinicallysignificantpleuraleffusioninintensivecareaprospectivemulticentercohortstudy
AT mattocknicholas clinicallysignificantpleuraleffusioninintensivecareaprospectivemulticentercohortstudy
AT mccloskeycassandra clinicallysignificantpleuraleffusioninintensivecareaprospectivemulticentercohortstudy
AT littonedward clinicallysignificantpleuraleffusioninintensivecareaprospectivemulticentercohortstudy
AT wibrowbradley clinicallysignificantpleuraleffusioninintensivecareaprospectivemulticentercohortstudy
AT hokwokm clinicallysignificantpleuraleffusioninintensivecareaprospectivemulticentercohortstudy
AT leeycgary clinicallysignificantpleuraleffusioninintensivecareaprospectivemulticentercohortstudy